Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review

Current Drug Targets

Volumn 12, Issue 1, 2011, Pages 29-41

  Meems, Laura M G ^a   van der Harst, P ^a   van Gilst, W H ^a   de Boer, R A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Heart failure; Hypertrophy; Renin; Renin angiotensin system; Vitamin D; Vitamin D receptor

Indexed keywords

CYTOKINE; RENIN; VITAMIN D; VITAMIN D RECEPTOR;

ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HEART FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; PREVALENCE; REVIEW; SYSTEMATIC REVIEW; VITAMIN D DEFICIENCY;

ANIMALS; DIETARY SUPPLEMENTS; HEART FAILURE; HUMANS; MOLECULAR TARGETED THERAPY; MYOCARDIUM; RECEPTORS, CALCITRIOL; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SIGNAL TRANSDUCTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78650865143     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945011793591554     Document Type: Review

References (99)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis treatment of acute, chronic heart failure 2008. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933-89.
2. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153: 937-42.
3. Krum H, Abraham WT. Heart failure. Lancet 2009; 373: 941-55.
4. Kuipers I, van der Harst P, Kuipers F, et al. Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system. Lab Invest 2010; 90: 630-6.
5. Kuipers I, van der Harst P, Navis G, et al. Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system. Hypertension 2008; 51: 1442-8.
6. Gouni-Berthold I, Krone W, Berthold H K. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 2009; 7: 414-22.
7. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
8. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353-73.
9. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
10. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805-6.
11. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitami-nosis D in medical inpatients. N Engl J Med 1998; 338: 777-83.
12. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142-6.
13. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-6.
14. Holick MF, Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action, and clinical application. In: Favus MJ, Ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Washington DC 2006; pp. 129-37.
15. Bouillon R. Vitamin D: from photosynthesis, metabolism, and action to clinical applications. In: DeGroot LJ, Jameson JL, Ed. Endocrinology. Philadelphia: W.B. Saunders 2001; pp. 1009-28.
16. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80(Suppl): 1689-96.
17. Baker AR, McDonnell DP, Hughes M, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85: 3294-8.
18. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25- dihydroxivitamin D3 receptors and activities in muscle. J Biol Chem 1985; 260: 8882-91.
19. TD O'Connell, RU Simpson. Immunochemical identification of the 1,25dihydroxivitamin D3 receptor protein in human heart. Cell Biol Inter 1996; 9: 621-4.
20. Chen S, Glenn DJ, Ni W, et al. Expression of the Vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008; 52: 1106-12.
21. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the T-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinolgy 2008; 149: 558-64.
22. Zella LA, Meyer MB, Nerenz RD, Lee Sm, Martowicz ML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol 2010; 24: 128-47.
23. Bouillon, Carmeliet G, Verlinden L, et al. VDR null phenotype. Endocrine Rev 2008; 29: 726-76.
24. McKinsey TA, Olson EN. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 2005; 115: 538-46.
25. Brown JH, Del Re DP, Sussman MA. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 2006; 98: 730-42.
26. Alderman MH, Ooi WL, Cohen H, Madhavan S, Sealey JE, Laragh JH. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens 1997; 10: 1-8.
27. [27] Latini R, Masson S, Anand I, Salio M, Hester. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004; 25: 292-9.
28. Kristal-Boneh E, Froom P, Harari G, Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997; 30: 1289-94.
29. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8: 894-901.
30. Burgess ED, Hawkins RG, Watanabe M. Interaction of 1,25- dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990; 3: 903-5.
31. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105: 649-54.
32. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25- Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-38.
33. Sigmund CD. Regulation of renin expression and blood pressure by vitamin D(3). J Clin Invest 2002; 110: 155-6.
34. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55: 1283-8.
35. Kimura Y, Kawamura M, Owada M, et al. Effectiveness of 1,25- dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern Med 1999; 38: 31-5.
36. Park CW, Oh YS, Shin YS, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 73-81.
37. Margolis KL, Ray RM, van Horn L, et al. Women's Health Initiative Investigators. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008; 52: 847-55.
38. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2007; 103: 416-9.
39. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003; 88: 327-31.
40. Zhou C, Fengxiang L, Kejiang C, Di X, Goltzman D, Dengshun M. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice. Kidney Inter 2008; 74: 170-9.
41. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288: 125-32.
42. Fryer RM, Rakestraw PA, Nakane M, et al. Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. Nephron Physiol 2007; 106: 76-81.
43. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 2008; 105: 15896-901.
44. Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007; 104: 16810-5.
45. Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383-92.
46. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003; 41: 105-12.
47. de Boer RA, Henning RH, Suurmeijer AJ, et al. Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease. Int J Cardiol 2001; 78: 5-12.
48. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-8.
49. Wu J, Garami M, Cao L, Li Q, Gardner DG. 1,25(OH)2D3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes. Am Physiol Soc 1995; 268: 1108-13.
50. McMurray J, Hiller C. The rise and fall of myotrophin in heart failure. J Am Coll Cardiol 2003; 42: 726-7.
51. Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU. 1,25(OH)2vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007; 103: 533-7.
52. Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003; 144: 5138-44.
53. Park EA. The etiology of rickets. Physiol Rev 1923; 3: 106.
54. O'Connell TD, Berry JE, Jarus AK, Somerman MJ, Simpson RU. 1,25-dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997; 272: 1751-8.
55. Green JJ, Robinson DA, Wilson GE, Simpson RU, Westfall MV. Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol 2006; 41: 350-9.
56. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755-60.
57. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823-25.
58. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983; 113: 1511-18.
59. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female types 2 diabetic population. Diabetes Care 2001; 24: 1496.
60. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-5.
61. Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 1984; 73: 759-66.
62. Nyomba BL, Bouillon R, de Moor P. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 1984; 115: 191-7.
63. Auwerx J, Bouillon R, Kesteloot H. Relation between 25- hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 1992; 12: 671.
64. Heikkinen AM, Tuppurainen MT, Niskanen L, Komulainen M, Penttila I, Saarikoski S: Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997; 137: 495.
65. Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 2008; 105: 5207-12.
66. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1- alpha,25-hydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005; 35: 217-24.
67. Michel G, Gailis A, Jarzebska-Deussen B, Muschen A, Mirmohammadsadegh A, Ruzicka T. 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm Res 1997; 46: 32-4.
68. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 1-alpha,25-dihydroxivitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001; 145: 351-7.
69. Kell R, Haunstetter A, Dengler TJ, Zugck C, Kubler W, Haass M. Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis. Eur Heart J 2002; 23: 70-8.
70. McKenna M. Differences in vitamin D status between countries in young adults and elderly. Am J Med 1992; 93: 69-77.
71. Kriegsman DM, Deeg DJ, van Eijk JT, Penninx BW, Boeke AJ. Do disease characteristics add to the explanation of mobility limitations in patients with different chronic diseases? A study in the Netherlands. J Epidemiol Commun Health 1997; 51: 676-85.
72. Albanese MC, Plewka M, Gregori D, et al. Use of medical resources and quality of life of patients with chronic heart failure: A prospective survey in a large Italian community hospital. Eur J Heart Fail 1999; 1: 411-7.
73. Zittermann A, Sabatschus O, Jantzen S, et al. Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels in comparison to age-matched sedentary controls. Calcif Tissue Int 2000; 67: 215-9.
74. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 2006; 11: 25-33.
75. Wilke RA, Simpson RU, Mukesh BN, et al. Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics 2009; 10: 1789-97.
76. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997; 103: 197-207.
77. Pilz S, März W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93: 3927-35.
78. Wang AY, Lam CW, Sanderson JE, et al. Serum 25- hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008; 87: 1631-8.
79. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008; 102: 1540-4.
80. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 2010; 8: 11-8.
81. Zittermann A, Schleithoff SS, Frisch S, et al. Circulating calcitriol concentrations and total mortality. Clin Chem 2009; 55: 1163-70.
82. Kilkkinen A, Knekt P, Aro A, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009; 170: 1032-9.
83. Arroyo M, Laguardia SP, Bhattacharya SK, et al. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res 2006; 148: 301-8.
84. Bolland MJ, Bacon CJ, Horne AM, et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr 2010; 91: 82-9.
85. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-54.
86. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profile in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-9.
87. Kim HW, Park CW, Shin YS, et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract 2006; 102: c21-9.
88. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 2010; 3: 195-201.
89. Todorov VT, Desch M, Schmitt-Nilson N, Todorova A, Kurtz A. Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression. Hypertension 2007; 50: 939- 44.
90. de Boer RA, Martens FM, Kuipers I, Boomsma F, Visseren FL: The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus. J Hum Hypertens 2010; 24: 74-6.
91. Ameri P, Ronco D, Casu M, et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: An echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 2010; [Epub ahead of print].
92. Abou-Raya S, Abou-Raya A. Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden. Arch Gerontol Geriatr 2009; 49: 250-4.
93. Alsafwah S, Laguardia SP, Nelson MD, et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008; 335: 292-7.
94. Zittermann A, Schleithoff SS, Götting C, et al. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008; 10: 321-7.
95. Zittermann A, Fischer J, Schleithoff SS, Tenderich G, Fuchs U, Koerfer R. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res 2007; 77: 280-8.
96. Saadi HF, Nicholls MG, Frampton CM, Benedict S, Yasin J. Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women. BMC Endocr Disord 2009; 9: 4.
97. Kenny AM, Boxer R, Walsh S, Hager WD, Raisz LG. Femoral bone mineral density in patients with heart failure. Osteoporos Int 2006; 17: 1420-7.
98. Pilz S, Henry RM, Snijder MB, et al. Vitamin D deficiency and myocardial structure and function in older men and women: the Hoorn study. J Endocrinol Invest 2010 [E-pub ahead of print].
99. Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008; 56: 454-61.